Evidence map›Paper›PMID 35641782›Full record

ArticleCell death and differentiation2022

DJ-1 binds to Rubicon to Impair LC-3 Associated Phagocytosis.

Sahil Gupta, Hajera Amatullah, James N Tsoporis, Kuiru Wei, Ana Paula Teixeira Monteiro, Amin M Ektesabi, Amir K Varkouhi, Chirag M Vaswani, Amanda Formosa, Alexandre T Fabro and 11 more

Abstract read
In one paragraph

Article in Cell death and differentiation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Sahil Gupta *The Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Unity Health Toronto, 209 Victoria Street, Toronto, ON, M5B1T8, Canada.
Hajera Amatullah *The Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Unity Health Toronto, 209 Victoria Street, Toronto, ON, M5B1T8, Canada.
James N TsoporisThe Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Unity Health Toronto, 209 Victoria Street, Toronto, ON, M5B1T8, Canada.
Kuiru WeiThe Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Unity Health Toronto, 209 Victoria Street, Toronto, ON, M5B1T8, Canada.
Ana Paula Teixeira MonteiroThe Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Unity Health Toronto, 209 Victoria Street, Toronto, ON, M5B1T8, Canada.
Amin M EktesabiThe Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Unity Health Toronto, 209 Victoria Street, Toronto, ON, M5B1T8, Canada.
Amir K VarkouhiThe Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Unity Health Toronto, 209 Victoria Street, Toronto, ON, M5B1T8, Canada.
Chirag M VaswaniThe Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Unity Health Toronto, 209 Victoria Street, Toronto, ON, M5B1T8, Canada.
Amanda FormosaThe Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Unity Health Toronto, 209 Victoria Street, Toronto, ON, M5B1T8, Canada.
Alexandre T FabroDepartment of Pathology and Legal Medicine, Taleles, Ribeirão Preto, São Paulo, 14049-900, Brazil.
Sri Nagarjun BatchuThe Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Unity Health Toronto, 209 Victoria Street, Toronto, ON, M5B1T8, Canada.
Chris FjellCentre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, BC, V6Z 1Y6, Canada.
James A RussellCentre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, BC, V6Z 1Y6, Canada.
Keith R WalleyCentre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, BC, V6Z 1Y6, Canada.
Andrew AdvaniThe Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Unity Health Toronto, 209 Victoria Street, Toronto, ON, M5B1T8, Canada.
Thomas G ParkerThe Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Unity Health Toronto, 209 Victoria Street, Toronto, ON, M5B1T8, Canada.
John C MarshallThe Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Unity Health Toronto, 209 Victoria Street, Toronto, ON, M5B1T8, Canada.
Patricia R M RoccoLaboratory of Pulmonary Investigation, Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, 21941-902, Brazil.
Gregory D FairnThe Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Unity Health Toronto, 209 Victoria Street, Toronto, ON, M5B1T8, Canada.
Tak Wah MakPrincess Margaret Cancer Centre, Princess Margaret Hospital, 610 University Avenue, Toronto, ON, M5G 2C1, Canada.ORCID 0000-0001-6766-861X
Claudia C Dos SantosThe Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Unity Health Toronto, 209 Victoria Street, Toronto, ON, M5B1T8, Canada. Claudia.dossantos@unityhealth.to.ORCID 0000-0002-6446-8791

Funding

CIHR MOP-130331
6 · The paper itself

Abstract

The ability to effectively clear infection is fundamental to host survival. Sepsis, defined as dysregulated host response to infection, is a heterogenous clinical syndrome that does not uniformly clear intact bacterial or sterile infection (i.e., lipopolysaccharide). These findings were further associated with increased survival in DJ-1 deficient animals exposed to intact bacteria relative to DJ-1 deficient challenged with lipopolysaccharide. We analyzed bacterial and lipopolysaccharide clearance in bone marrow macrophages (BMM) cultured ex vivo from wild-type and DJ-1 deficient mice. Importantly, we demonstrated that DJ-1 deficiency in BMM promotes Rubicon-dependent increase in L3C-associated phagocytosis, non-canonical autophagy pathway used for xenophagy, during bacterial but not lipopolysaccharide infection. In contrast to DJ-1 deficient BMM challenged with lipopolysaccharide, DJ-1 deficient BMM exposed to intact bacteria showed enhanced Rubicon complexing with Beclin-1 and UVRAG and consistently facilitated the assembly of complete autophagolysosomes that were decorated with LC3 molecules. Our data shows DJ-1 impairs or/and delays bacterial clearance and late autophagolysosome formation by binding to Rubicon resulting in Rubicon degradation, decreased L3C-associated phagocytosis, and decreased bacterial clearance in vitro and in vivo - implicating Rubicon and DJ-1 as critical regulators of bacterial clearance in experimental sepsis.

Indexed as

PhagocytosisSepsisAnimalsAutophagyAutophagy-Related ProteinsBeclin-1Intracellular Signaling Peptides and ProteinsLipopolysaccharidesMiceAutophagy-Related ProteinsBeclin-1Intracellular Signaling Peptides and ProteinsLipopolysaccharidesRubcn protein, mouse

Identifiers

PMID35641782
PMCPMC9525254

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.